• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项使用国际标准化比值稳定性对药师管理的抗凝门诊与医生管理进行回顾性评估的比较。

A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability.

机构信息

South University School of Pharmacy, St. Joseph's/Candler Health-System Anti-coagulation Clinic, 709 Mall Blvd, Savannah, GA 31406, USA.

出版信息

J Thromb Thrombolysis. 2011 Nov;32(4):426-30. doi: 10.1007/s11239-011-0612-7.

DOI:10.1007/s11239-011-0612-7
PMID:21710189
Abstract

To assess the rates of therapeutic international normalized ratio (INR) levels between pharmacist-managed clinics compared to traditional physician-management and to determine the variation in rates of therapeutic INR levels between pharmacist-managed clinic data compared to physician-management. Retrospective, randomized, chart review. Referral only, outpatient, pharmacist based anticoagulation clinic under a community based tertiary care health system. Sixty-four patients with at least 1 year's worth of visits to the pharmacist managed clinic were reviewed for INR stability. The average percentage of visits within the defined therapeutic range, was 71.1% for the physician-managed group versus 81.1% for the pharmacist-managed group (P < 0.0001). The estimated variance in average therapeutic INR rates was double for the physician-managed group (365.7) versus the pharmacist-managed group (185.2) (P = 0.004). The pharmacist-managed anti-coagulation clinic had higher rates of INRs determined to be therapeutic and also exhibited significantly less variability in therapeutic INR rates relative to the physician-managed service.

摘要

评估药师管理诊所与传统医师管理相比的治疗性国际标准化比值(INR)水平的比率,并确定药师管理诊所数据与医师管理相比的治疗性 INR 水平比率的变化。回顾性、随机、图表审查。仅转介,门诊,社区三级保健系统下的基于药师的抗凝诊所。对至少有 1 年就诊于药师管理诊所的 64 名患者进行 INR 稳定性评估。在规定的治疗范围内就诊的平均百分比,医生管理组为 71.1%,药师管理组为 81.1%(P < 0.0001)。医师管理组(365.7)与药师管理组(185.2)相比,平均治疗性 INR 率的估计方差高两倍(P = 0.004)。与医师管理服务相比,药师管理的抗凝诊所具有更高的 INR 治疗率,并且在治疗性 INR 率的变异性方面也显著降低。

相似文献

1
A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability.一项使用国际标准化比值稳定性对药师管理的抗凝门诊与医生管理进行回顾性评估的比较。
J Thromb Thrombolysis. 2011 Nov;32(4):426-30. doi: 10.1007/s11239-011-0612-7.
2
Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.华法林治疗稳定后从药剂师管理的抗凝门诊出院患者的抗凝治疗质量。
Pharmacotherapy. 2008 Jan;28(1):20-6. doi: 10.1592/phco.28.1.20.
3
Comparison of two different models of anticoagulation management services with usual medical care.两种不同抗凝管理服务模式与常规医疗护理的比较。
Pharmacotherapy. 2010 Apr;30(4):330-8. doi: 10.1592/phco.30.4.330.
4
Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.基于药师的与基于医生的抗凝管理在卡塔尔的比较评估。
J Eval Clin Pract. 2016 Jun;22(3):433-8. doi: 10.1111/jep.12504. Epub 2016 Jan 14.
5
International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic.药剂师管理的抗凝门诊中,分组预约与个体预约的国际标准化比值数值。
Am J Health Syst Pharm. 2009 Jul 1;66(13):1218-23. doi: 10.2146/ajhp080278.
6
Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.药师管理的住院患者抗凝治疗启动和滴定服务的疗效和安全性。
J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.
7
The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes.卡塔尔首个依据合作医疗协议设立的药剂师管理的抗凝门诊:临床及以患者为导向的结果
J Clin Pharm Ther. 2016 Aug;41(4):403-8. doi: 10.1111/jcpt.12400. Epub 2016 May 4.
8
Evaluation of differences in percentage of international normalized ratios in range between pharmacist-led and physician-led anticoagulation management services.评估药师主导和医生主导的抗凝管理服务中国际标准化比值处于特定范围的百分比差异。
J Pharm Pract. 2015 Jun;28(3):249-55. doi: 10.1177/0897190013516368. Epub 2013 Dec 30.
9
Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic.慢性肾脏病对抗凝门诊药师管理华法林治疗的影响。
J Manag Care Pharm. 2011 Sep;17(7):523-30. doi: 10.18553/jmcp.2011.17.7.523.
10
Evaluating warfarin management by pharmacists in a community teaching hospital.评估社区教学医院中药剂师对华法林的管理情况。
Consult Pharm. 2014 Feb;29(2):95-103. doi: 10.4140/TCP.n.2014.95.

引用本文的文献

1
Preemptive Dose Adjustment Effect on the Quality of Anticoagulation Management in Warfarin Patients With Drug Interactions: A Retrospective Cohort Study.药物相互作用的华法林患者预防性剂量调整对抗凝管理质量的影响:一项回顾性队列研究。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619872554. doi: 10.1177/1076029619872554.
2
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.美国血液学会 2018 年静脉血栓栓塞症管理指南:抗凝治疗的最佳管理。
Blood Adv. 2018 Nov 27;2(22):3257-3291. doi: 10.1182/bloodadvances.2018024893.
3
Patient Education on Oral Anticoagulation.

本文引用的文献

1
Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate.对新型口服抗凝治疗处方的依从性:达比加群酯
Patient Prefer Adherence. 2009 Nov 3;3:173-7. doi: 10.2147/ppa.s3682.
2
The new oral anticoagulants.新型口服抗凝药物。
Blood. 2010 Jan 7;115(1):15-20. doi: 10.1182/blood-2009-09-241851. Epub 2009 Oct 30.
3
Reduced reimbursement for cardiovascular services by the Centers for Medicare and Medicaid Services: perspective from interventional cardiology.医疗保险和医疗补助服务中心对心血管服务报销费用的削减:来自介入心脏病学的视角
口服抗凝治疗的患者教育
Pharmacy (Basel). 2018 Apr 20;6(2):34. doi: 10.3390/pharmacy6020034.
4
Quality of anticoagulation management with warfarin among outpatients in a tertiary hospital in Addis Ababa, Ethiopia: a retrospective cross-sectional study.埃塞俄比亚亚的斯亚贝巴一家三级医院门诊患者华法林抗凝管理质量:一项回顾性横断面研究。
BMC Health Serv Res. 2017 Jun 6;17(1):389. doi: 10.1186/s12913-017-2330-0.
5
Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives.日本由药剂师管理的患者教育与咨询诊所:现状与未来展望。
J Pharm Health Care Sci. 2015 Jan 28;1:2. doi: 10.1186/s40780-014-0001-4. eCollection 2015.
JACC Cardiovasc Interv. 2009 Sep;2(9):894-6. doi: 10.1016/j.jcin.2009.08.002.
4
Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.新型口服抗栓药物的出现:对其临床潜力的批判性评估。
Vasc Health Risk Manag. 2008;4(6):1373-86. doi: 10.2147/vhrm.s3266.
5
The novel anticoagulants: entering a new era.新型抗凝剂:步入新时代。
Swiss Med Wkly. 2009 Feb 7;139(5-6):60-4. doi: 10.4414/smw.2009.12447.
6
New issues in oral anticoagulants.
Hematology Am Soc Hematol Educ Program. 2008:259-65. doi: 10.1182/asheducation-2008.1.259.
7
Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.达比加群酯:一种用于预防和治疗血栓栓塞性疾病的口服直接凝血酶抑制剂。
Pharmacotherapy. 2008 Nov;28(11):1354-73. doi: 10.1592/phco.28.11.1354.
8
Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic.抗凝门诊患者结局与家庭医学门诊传统护理结局的比较。
J Am Board Fam Pract. 2001 Jan-Feb;14(1):16-21.
9
Warfarin therapy: evolving strategies in anticoagulation.华法林治疗:抗凝治疗策略的演变
Am Fam Physician. 1999 Feb 1;59(3):635-46.
10
Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.抗凝门诊与常规医疗护理的比较:抗凝控制、患者预后及医疗保健成本。
Arch Intern Med. 1998;158(15):1641-7. doi: 10.1001/archinte.158.15.1641.